Cryptenamine

{{Drugbox

| verifiedrevid = 427075222

| drug_name = Cryptenamine

| type = combo

| component1 = Veratrum alkaloids

| class1 = Antihypertensive

| component2 = Tannic acid

| class2 = Counterion

| IUPAC_name =

| image = Protoveratrine A.svg

| alt =

| caption = Protoveratrine A, the main constituent of cryptenamine

| tradename =

| Drugs.com =

| MedlinePlus =

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category=

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number = 1356-18-9

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = QVO4N8484O

| ATCvet =

| ATC_prefix =

| ATC_suffix =

| PubChem =

| DrugBank = DB00785

| ChemSpiderID = none

| chemical_formula =

| molecular_weight =

}}

Cryptenamine (Unitensen) is a mixture of 10 hypotensive alkaloids extracted from Veratrum album (protoveratrines A and B; germitrine, neogermitrine, germerine, and germidine; jervine, rubijervine, and isorubijervine; and germbudine). It is a hypotensive{{cite journal | vauthors = Jandhyala BS, Buckley JP | title = Pharmacology and mechanism of action of cryptenamine | journal = Journal of Pharmaceutical Sciences | volume = 55 | issue = 9 | pages = 888–893 | date = September 1966 | pmid = 5918523 | doi = 10.1002/jps.2600550903 }}{{cite journal | vauthors = Jandhyala ML, Buckley JP | title = Mechanisms of action of cryptenamine | journal = Journal of Pharmaceutical Sciences | volume = 57 | issue = 9 | pages = 1576–1582 | date = September 1968 | pmid = 5674398 | doi = 10.1002/jps.2600570923 }} and used in the treatment of hypertension.{{DrugBank|DB00785}}